for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Fancl Corp

4921.T

Latest Trade

2,860.00JPY

Change

14.00(+0.49%)

Volume

448,500

Today's Range

2,831.00

 - 

2,882.00

52 Week Range

2,082.50

 - 

3,330.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2,846.00
Open
2,845.00
Volume
448,500
3M AVG Volume
19.07
Today's High
2,882.00
Today's Low
2,831.00
52 Week High
3,330.00
52 Week Low
2,082.50
Shares Out (MIL)
120.05
Market Cap (MIL)
370,985.20
Forward P/E
31.84
Dividend (Yield %)
1.05

Next Event

Q2 2020 Fancl Corp Earnings Release

Latest Developments

More

Fancl Completes Share Repurchase

Fancl to repurchase up to 8.5 mln shares for 22 bln yen

Fancl to merge with Nagano-based unit

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Fancl Corp

FANCL CORPORATION is a Japan-based company principally engaged in the research, development, manufacture and sale of cosmetics and dietary supplements. The Company operates in three business segments. Cosmetics segment is involved in the manufacture and sale of cosmetics, as well as the supply of original equipment manufacturer (OEM). Dietary Supplement Related segment manufactures and sells dietary supplements. Others segment provides miscellaneous goods, underwear, accessories, germinated rice and green juice (aojiru).

Industry

Personal & Household Prods.

Contact Info

FANCL Bldg.

89-1, Yamashita-cho, Naka-ku

+81.45.2261200

https://www.fancl.jp/

Executive Leadership

Kenji Ikemori

Chairman of the Executive Board, Founder, Representative Director

Kazuyuki Shimada

Executive President, Chief Executive Officer, Chief Director of Marketing, Representative Director

Kazuyoshi Miyajima

Vice Chairman of the Executive Board, Director

Yukihiro Ishigami

Chief Financial Officer, Senior Executive Officer, Chief Dir of Business Planning, Dir

Tomochika Yamaguchi

Senior Managing Executive Officer, Chief Director of Store Sales, Director

Key Stats

1.88 mean rating - 8 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.1K

2018

0.1K

2019

0.1K

2020(E)

0.1K
EPS (JPY)

2017

40.960

2018

48.830

2019

68.820

2020(E)

89.326
Price To Earnings (TTM)
43.82
Price To Sales (TTM)
2.99
Price To Book (MRQ)
5.54
Price To Cash Flow (TTM)
33.06
Total Debt To Equity (MRQ)
16.58
LT Debt To Equity (MRQ)
16.58
Return on Investment (TTM)
10.68
Return on Equity (TTM)
8.83

Latest News

Latest News

Brewer Kirin to buy 30.3% stake in cosmetics firm Fancl for $1.2 billion

Japanese brewer Kirin Holdings Co Ltd <2503.T> said on Tuesday it would take a 30.3% stake in cosmetics company Fancl Corp <4921.T> for 129 billion yen ($1.21 billion) as it reduces its exposure to the shrinking domestic beer market.

Kirin to take 30.3% stake in Fancl for $1.2 bln

Japanese brewer Kirin Holdings Co Ltd said on Tuesday it would take a 30.3% stake in cosmetics company Fancl Corp for 129 billion yen ($1.21 billion) as it reduces its exposure to the shrinking domestic beer market.

BRIEF-Fancl to merge with Nagano-based unit

* Says Nagano-based germinated brown rice unit will transfer germinated brown rice business to Chiba-based unit, which is engaged in manufacture of cosmetics and health foods,

BRIEF-Fancl Corp's nutritional supplements segment sees FY operating profit of 1.1 bln yen - Nikkei

* Fancl Corp's nutritional supplements segment sees FY operating profit of 1.1 billion yen and FY sales growth of 11pct to 35.5 billion yen- Nikkei Source :(http://s.nikkei.com/2rNONpi) Further company coverage:

BRIEF-Fancl to sign distributorship agreement with China medical company

* Says it will sign a distributorship agreement with a China-based company, which is mainly engaged in import and export of food and medicine material, providing of international medical technology, as well as operation of public hospital

BRIEF-Fancl names Kazuyuki Shimada as president and CEO

Fancl Corp : * Says it names Kazuyuki Shimada as president and CEO * Says effective April 1 Source text in Japanese:https://goo.gl/234TKz Further company coverage: (Beijing Headline News)

BRIEF-Fancl to merge wholly owned cosmetics unit and dietary supplement unit

* Says the co plans to merge two wholly owned units on April 1

BRIEF-ReproCell to develop human iPS cells jointly with Fancl Corp

* Says it entered into agreement with Fancl Corp to jointly develop human iPS cells since Nov. 16

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up